Back

Applicability and prognostic value of new proposed criteria for atrial cardiomyopathy in patients with heart failure

31 August 2026 (08:35 - 08:45)
Organised by: Logo
Congress Presentation Part of: Risk prediction and prognosis in heart failure Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Hiroki Uehara

Hokkaido University, Sapporo (Japan)

5 More presentations in this session

Presentation thumbnail
Beyond LVEF: morbidity burden (GMA) as the main predictor of mortality and outcomes in heart failure
Doctor H. Tizon Marcos (Barcelona, ES)
Abstract
Presentation thumbnail
Risk of dementia and mortality in patients with heart failure - a danish nationwide cohort study
Mr M. Blenkov (DK)
Abstract
Presentation thumbnail
U-shaped association of HbA1c levels with incident cancer risk in patients with heart failure and type 2 diabetes mellitus
Miss Y. Qi (HK)
Abstract
Presentation thumbnail
Heart failure clinic follow-up and outcomes after hospitalisation: a propensity-weighted cohort study
Mr J. Rolland (Oslo, NO)
Abstract
Presentation thumbnail
Whole-genome landscapes of 1186 end stage heart failure patients undergoing heart transplantation
Doctor S. Xu (Beijing, CN)
Abstract

Access the full session

Session thumbnail
Risk prediction and prognosis in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 08:35 CET
You may be interested in
thumbnail
Congress Presentation
Atrial cardiomyopathy in middle-aged patients with atrial fibrillation
23 May 2023
thumbnail
Congress Presentation
Prognostic utility of atrial cardiomyopathy, HFA-PEFF, and H2FPEF scores in patients with sick sinus syndrome
12 April 2026
thumbnail
Congress Presentation
P-wave morphology based diagnosis of atrial cardiomyopathy in heart failure with preserved ejection fraction (HFpEF) patients with and without known atrial fibrillation (AF)
30 March 2025
thumbnail
Congress Presentation
The risk of cardiac hospitalization and arrythmias in patients with arrhythmogenic and dilated cardiomyopathies
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources